PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

Tue, 01st Aug 2023 17:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Rockfire Resources PLC - Greece and Australia-focused gold, base metal and critical mineral exploration company - Announces the company's geotechnical drilling, has intersected high-grade zinc, silver and lead at its 100%-owned Molaoi zinc deposit in Greece. David Price, chief executive says: "These drilling results continue to demonstrate the quality of the Molaoi zinc/lead/silver deposit. Our drilling is designed to obtain sufficient sample volume for crushing and grinding work index studies. Whilst achieving this principal goal, this drilling continues to confirm and infill 179 historical drillholes which were drilled at Molaoi in the 1980's."

----------

Petroneft Resources PLC - oil and gas exploration company focussed on Russia - Enters non-binding heads of terms with Pavel Tetyakov, chief executive, to sell WorldAce Investments Ltd and OOO Granite Construction for around USD110. Completion of the sale would mark its full exit from Russia.

----------

Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Mid Yorkshire Teaching NHS Trust has this week started the first UK pilot evaluation of Ondine's steriwave nasal photodisinfection for the prevention of surgical site infections. The six-month pilot will see 500 elective hip and knee surgery patients nasally decolonized using steriwave prior to their surgery. Ondine says it is in discussions with a number of other NHS trusts about initiating additional steriwave pilots.

----------

C4X Discovery Holdings PLC - Manchester, England-based drug discovery firm focussed on immuno-inflammatory diseases - Sells proprietary rights to C4XD's oral orexin-1 receptor antagonist, C4X_3256 for substance use disorder, to Indivior PLC for GBP16.0 million. Completion of this divestment forms part of C4XD's evolution towards becoming an immuno-inflammatory therapeutics company. Explains a previous license agreement announced in 2018 will be terminated and Indivior will assume all rights related to the development and use of C4X_3256 and related compounds.

----------

Engage XR Holdings PLC - Waterford, Ireland-based virtual reality software and technology group - Provides update on trading for six to June 30. Continues to trade in line with market expectations. Expects revenue of around EUR2.1 million, up 18% on EUR 1.8 million the year prior. Main driver is increase in revenue is Engage with revenue up 30% to EUR1.9 million, or 91% of the group total. Gross margin improved to 93% from 81%. Gaining transaction in the US with 54% of revenue deriving from North America, up from 30% in the previous year.

----------

Digitalbox PLC - digital media and owner of brands such as Daily Mash, The Poke and The Tab - Buys the digital assets of 99 Problems, Student Problems and The Life Network Shopping from Media Chain Group Ltd for USD800,000. Expects acquisition to be immediately earnings enhancing on completion. Notes the deal provides Digitalbox with the opportunity to extend its audience reach through the 99 Problems 10 million Facebook followers, Student Problems 1.4 million Tik Tok followers and the The Life Shopping Network 1 million Facebook followers. Deal will be funded from existing resources.

----------

San Leon Energy PLC - Dublin-headquartered oil and gas company focused on Nigeria - Announces a further extension to the longstop dates for the proposed transactions with Midwestern Oil & Gas Co Ltd and the company's further investments in Energy Link Infrastructure (Malta) Ltd. These were announced on July 8. All longstop dates have, in agreement with Midwestern and the other relevant parties, been extended to August 31. Remains optimistic on progress being made and expects to provide an update to shareholders in the near term.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 May 2020 17:57

C4X Discovery Raises GBP1.6 Million Via Share Placing

C4X Discovery Raises GBP1.6 Million Via Share Placing

Read more
24 Jan 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jan 2020 10:40

C4X Discovery Annual Loss Widens, Confident In Strategy

C4X Discovery Annual Loss Widens, Confident In Strategy

Read more
7 Jan 2020 09:59

C4X losses widen as its revenue drops to nil

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced a fall in revenue to nil in its full-year results on Tuesday, from £7.06m in 2018, which the board said as driven entirely by the Indivior licensing agreement in that year.

Read more
31 Dec 2019 10:47

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Oct 2019 17:06

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

Read more
24 Oct 2019 11:09

C4X Discovery Raises Over GBP5 Million In Discounted Placing

C4X Discovery Raises Over GBP5 Million In Discounted Placing

Read more
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
1 Oct 2019 10:15

C4X makes solid progress across portfolio of programmes

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced progress across a number of key programmes in line with its strategy on Tuesday, reporting that it was continuing to progress its strategy to deliver programmes for out-licensing its NRF-2 activator, IL-17 inhibitor and LifeArc collaboration.

Read more
27 Sep 2019 15:39

C4X upbeat as its molecule progresses with Indivior

(Sharecast News) - Drug discovery company C4X Discovery Holdings noted an announcement on Friday that the National Institutes of Health (NIH) in the United States has granted Indivior's application titled "Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder'.

Read more
2 Sep 2019 12:02

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.Shares in C4X were up

Read more
30 Apr 2019 12:59

C4X Discovery Interim Loss Widens, Focuses On Inking Deals

LONDON (Alliance News) - C4X Discovery Holdings PLC said on Tuesday it had a "strong" first half, though its loss widened on higher research and development costs.The drug firm to

Read more
23 Apr 2019 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 24 April PetropavolskFull Year ResultsBoohoo GroupFull Year HealthFull

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.